{"schema_version":"1","generated_at":"2026-11-03T00:29:26.949Z","data_as_of":null,"url":"https://www.findmykol.com/kol/thomas-spitzer","json_url":"https://www.findmykol.com/kol/thomas-spitzer/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"thomas-spitzer","name":"Thomas Spitzer","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1477543783","orcid":"0000-0003-1384-5742","openalex":"A5036475373"},"summary":"Thomas Spitzer is a Hematology physician affiliated with Harvard University. OpenAlex indexes 386 publications with 14,649 citations (h-index 59); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":386,"cited_by_count":14649,"h_index":59,"latest_activity_year":2025,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02158052","title":"Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Massachusetts General Hospital","source_url":"https://clinicaltrials.gov/study/NCT02158052","trial_url":"https://www.findmykol.com/trial/NCT02158052"},{"nct":"NCT00854139","title":"Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Massachusetts General Hospital","source_url":"https://clinicaltrials.gov/study/NCT00854139","trial_url":"https://www.findmykol.com/trial/NCT00854139"},{"nct":"NCT00113828","title":"Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Massachusetts General Hospital","source_url":"https://clinicaltrials.gov/study/NCT00113828","trial_url":"https://www.findmykol.com/trial/NCT00113828"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Genetix Biotherapeutics Inc","program_year":2025,"amount_usd":4930,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477543783"},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2024,"amount_usd":4666.71,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477543783"},{"payer":"SANOFI-AVENTIS U.S. LLC","program_year":2024,"amount_usd":1662,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477543783"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1477543783","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":1994,"last":2002},"rows_total":7,"shown":3,"withheld":4,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA079986","title":"MIXED CHIMERISM FOLLOWING BMT FOR HEMATOLOGIC MALIGNANCY","fiscal_year":2002,"amount_usd":"314405","organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01CA079986"},{"project":"R01CA079986","title":"MIXED CHIMERISM FOLLOWING BMT FOR HEMATOLOGIC MALIGNANCY","fiscal_year":2001,"amount_usd":"305248","organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01CA079986"},{"project":"R01CA079986","title":"MIXED CHIMERISM FOLLOWING BMT FOR HEMATOLOGIC MALIGNANCY","fiscal_year":2000,"amount_usd":"316268","organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01CA079986"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial","year":2022,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2021014738","status":"verified"},{"title":"UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial","year":2022,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(22)00245-9","status":"verified"},{"title":"Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)","year":2022,"journal":"Journal for ImmunoTherapy of Cancer","source_url":"https://doi.org/10.1136/jitc-2021-003847","status":"verified"},{"title":"Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies","year":2020,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(20)32334-5","status":"verified"},{"title":"Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity","year":2018,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2018017731","status":"verified"}],"source":"works"},"contact":{"address_1":"55 FRUIT ST","address_2":"ZERO EMERSON PLACE SUITE 118","city":"Boston","state":"MA","zip":"021142621","phone":"617-724-1124","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1477543783","source":"identity"},"similar":[{"name":"Thoralf Sundt","slug":"thoralf-sundt","institution":"Harvard University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/thoralf-sundt","json_url":"https://www.findmykol.com/kol/thoralf-sundt/profile.json"},{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":1,"funding":4,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-09-22","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}